NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001493

Registered date:10/11/2008

Effects of extract of decaffeinated green coffee beans on postprandial serum glucose in healthy subjects.

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedhyperglycemia
Date of first enrollment2007/05/01
Target sample size45
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)1) A total of 41 subjects (22 men and 19 women ) without type 2 diabetes were enrolled in the present study. 2) Test meals of 200g of a carbohydrate-rich meal plus placebo (200ml) were administered in a double-blind trial. 3) Antecubital venous blood was collected before the meal and at t = 0.5, 1, 1.5 and 2 h, where t = 0 was the start of test meal ingestion. 1) A total of 41 subjects (22 men and 19 women ) without type 2 diabetes were enrolled in the present study. 2) Test meals of 200g of a carbohydrate-rich meal plus extract of decaffeinated green coffee beans (100mg/200ml water) were administered in a double-blind trial. 3) Antecubital venous blood was collected before the meal and at t = 0.5, 1, 1.5 and 2 h, where t = 0 was the start of test meal ingestion. 1) A total of 41 subjects ( 22 men and 19 women ) without type 2 diabetes were enrolled in the present study. 2) Test meals of 200g of a carbohydrate-rich meal plus extract of decaffeinated green coffee beans (300mg/200ml water) were administered in a double-blind trial. 3) Antecubital venous blood was collected before the meal and at t = 0.5, 1, 1.5 and 2 h, where t = 0 was the start of test meal ingestion.

Outcome(s)

Primary Outcome1) Postprandial serum glucose (0,30,60,90, and 120min) and AUC (0-120min) 2) Postprandial serum insulin (0,30,60,90, and 120min) and AUC (0-120min)
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum50years-old
GenderMale and Female
Include criteria
Exclude criteria1) Individuals who do not usually eat breakfast. 2) Individuals taking drugs which affect the glucose level. 3) Individuals taking supplements which improve the glucose level. 4) Individuals judged to have diabetes mellitus. 5) Individuals with serious complications or with a disease which urgently needs treatment. 6) Individuals with a chronic disease. 7) Individuals with a digestive system disease and with a history of digestive organ surgery. 8) Individuals with a medical record of drug or alcohol dependence. 9) Pregnant women, or women with intending to become pregnant, and lactating women. 10) Individuals participating or intending to participate in a drug administration test. 11) Individuals judged by the doctor to be unsuitable.

Related Information

Contact

public contact
Name Kazuya IWAI
Address Japan
Telephone
E-mail
Affiliation UCC Ueshima Coffee, Co., Ltd. R&D center
scientific contact
Name Taiji FUKUNAGA
Address 3-1-4, Zushi, Takatsuki-shi, Osaka,Japan 569-0036 Japan
Telephone
E-mail
Affiliation UCC Ueshima Coffee, Co., Ltd. R&D center